Etienne C Hirsch, Peter Jenner, Serge Przedborski. Mov Disord 2013
Times Cited: 175
Times Cited: 175
Times Cited
Times Co-cited
Similarity
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C Hirsch, Stéphane Hunot. Lancet Neurol 2009
Etienne C Hirsch, Stéphane Hunot. Lancet Neurol 2009
18
Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.
Malú G Tansey, Matthew S Goldberg. Neurobiol Dis 2010
Malú G Tansey, Matthew S Goldberg. Neurobiol Dis 2010
11
Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
11
Pharmacological treatment of Parkinson disease: a review.
Barbara S Connolly, Anthony E Lang. JAMA 2014
Barbara S Connolly, Anthony E Lang. JAMA 2014
11
A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection.
Francesca L'episcopo, Maria F Serapide, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C Morale, Stefano Pluchino, Bianca Marchetti. Mol Neurodegener 2011
Francesca L'episcopo, Maria F Serapide, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C Morale, Stefano Pluchino, Bianca Marchetti. Mol Neurodegener 2011
10
Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
10
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease.
Patrick P Michel, Etienne C Hirsch, Stéphane Hunot. Neuron 2016
Patrick P Michel, Etienne C Hirsch, Stéphane Hunot. Neuron 2016
9
Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.
Francesca L'Episcopo, Cataldo Tirolo, Salvo Caniglia, Nuccio Testa, Maria Concetta Morale, Maria Francesca Serapide, Stefano Pluchino, Bianca Marchetti. J Mol Cell Biol 2014
Francesca L'Episcopo, Cataldo Tirolo, Salvo Caniglia, Nuccio Testa, Maria Concetta Morale, Maria Francesca Serapide, Stefano Pluchino, Bianca Marchetti. J Mol Cell Biol 2014
16
Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair.
Francesca L'Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C Morale, Michela Deleidi, Maria F Serapide, Stefano Pluchino, Bianca Marchetti. J Neurosci 2012
Francesca L'Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C Morale, Michela Deleidi, Maria F Serapide, Stefano Pluchino, Bianca Marchetti. J Neurosci 2012
9
Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
F L'Episcopo, C Tirolo, N Testa, S Caniglia, M C Morale, C Cossetti, P D'Adamo, E Zardini, L Andreoni, A E C Ihekwaba,[...]. Neurobiol Dis 2011
F L'Episcopo, C Tirolo, N Testa, S Caniglia, M C Morale, C Cossetti, P D'Adamo, E Zardini, L Andreoni, A E C Ihekwaba,[...]. Neurobiol Dis 2011
9
Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation.
Francesca L'Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C Morale, Francesco Impagnatiello, Stefano Pluchino, Bianca Marchetti. J Neurosci 2013
Francesca L'Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C Morale, Francesco Impagnatiello, Stefano Pluchino, Bianca Marchetti. J Neurosci 2013
12
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.
J W Langston, L S Forno, J Tetrud, A G Reeves, J A Kaplan, D Karluk. Ann Neurol 1999
J W Langston, L S Forno, J Tetrud, A G Reeves, J A Kaplan, D Karluk. Ann Neurol 1999
9
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
8
8
Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice.
Francesca L'episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria Concetta Morale, Francesco Impagnatiello, Bianca Marchetti. Rejuvenation Res 2011
Francesca L'episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria Concetta Morale, Francesco Impagnatiello, Bianca Marchetti. Rejuvenation Res 2011
25
Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.
Francesca L'Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria Concetta Morale, Maria Francesca Serapide, Stefano Pluchino, Bianca Marchetti. Stem Cells 2014
Francesca L'Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria Concetta Morale, Maria Francesca Serapide, Stefano Pluchino, Bianca Marchetti. Stem Cells 2014
10
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.
Vanessa Brochard, Béhazine Combadière, Annick Prigent, Yasmina Laouar, Aline Perrin, Virginie Beray-Berthat, Olivia Bonduelle, Daniel Alvarez-Fischer, Jacques Callebert, Jean-Marie Launay,[...]. J Clin Invest 2009
Vanessa Brochard, Béhazine Combadière, Annick Prigent, Yasmina Laouar, Aline Perrin, Virginie Beray-Berthat, Olivia Bonduelle, Daniel Alvarez-Fischer, Jacques Callebert, Jean-Marie Launay,[...]. J Clin Invest 2009
8
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
M H Polymeropoulos, C Lavedan, E Leroy, S E Ide, A Dehejia, A Dutra, B Pike, H Root, J Rubenstein, R Boyer,[...]. Science 1997
M H Polymeropoulos, C Lavedan, E Leroy, S E Ide, A Dehejia, A Dutra, B Pike, H Root, J Rubenstein, R Boyer,[...]. Science 1997
8
To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?
Bianca Marchetti, Maria P Abbracchio. Trends Pharmacol Sci 2005
Bianca Marchetti, Maria P Abbracchio. Trends Pharmacol Sci 2005
8
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
J A Obeso, M Stamelou, C G Goetz, W Poewe, A E Lang, D Weintraub, D Burn, G M Halliday, E Bezard, S Przedborski,[...]. Mov Disord 2017
J A Obeso, M Stamelou, C G Goetz, W Poewe, A E Lang, D Weintraub, D Burn, G M Halliday, E Bezard, S Przedborski,[...]. Mov Disord 2017
8
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.
P L McGeer, S Itagaki, B E Boyes, E G McGeer. Neurology 1988
P L McGeer, S Itagaki, B E Boyes, E G McGeer. Neurology 1988
8
Protocol for the MPTP mouse model of Parkinson's disease.
Vernice Jackson-Lewis, Serge Przedborski. Nat Protoc 2007
Vernice Jackson-Lewis, Serge Przedborski. Nat Protoc 2007
7
Stages in the development of Parkinson's disease-related pathology.
Heiko Braak, Estifanos Ghebremedhin, Udo Rüb, Hansjürgen Bratzke, Kelly Del Tredici. Cell Tissue Res 2004
Heiko Braak, Estifanos Ghebremedhin, Udo Rüb, Hansjürgen Bratzke, Kelly Del Tredici. Cell Tissue Res 2004
7
Expanding insights of mitochondrial dysfunction in Parkinson's disease.
Patrick M Abou-Sleiman, Miratul M K Muqit, Nicholas W Wood. Nat Rev Neurosci 2006
Patrick M Abou-Sleiman, Miratul M K Muqit, Nicholas W Wood. Nat Rev Neurosci 2006
7
Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.
Ernest Arenas. J Mol Cell Biol 2014
Ernest Arenas. J Mol Cell Biol 2014
9
Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
Gaia Codolo, Nicoletta Plotegher, Tommaso Pozzobon, Marco Brucale, Isabella Tessari, Luigi Bubacco, Marina de Bernard. PLoS One 2013
Gaia Codolo, Nicoletta Plotegher, Tommaso Pozzobon, Marco Brucale, Isabella Tessari, Luigi Bubacco, Marina de Bernard. PLoS One 2013
7
Inflammation as a causative factor in the aetiology of Parkinson's disease.
P S Whitton. Br J Pharmacol 2007
P S Whitton. Br J Pharmacol 2007
7
Inflammation is genetically implicated in Parkinson's disease.
N Dzamko, C L Geczy, G M Halliday. Neuroscience 2015
N Dzamko, C L Geczy, G M Halliday. Neuroscience 2015
7
Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.
Jason R Cannon, J Timothy Greenamyre. Neurobiol Dis 2013
Jason R Cannon, J Timothy Greenamyre. Neurobiol Dis 2013
7
Glia as a turning point in the therapeutic strategy of Parkinson's disease.
Francesca L' Episcopo, Cataldo Tirolo, Nuccio Testa, Salvo Caniglia, Maria Concetta Morale, Bianca Marchetti. CNS Neurol Disord Drug Targets 2010
Francesca L' Episcopo, Cataldo Tirolo, Nuccio Testa, Salvo Caniglia, Maria Concetta Morale, Bianca Marchetti. CNS Neurol Disord Drug Targets 2010
13
Neurotoxic reactive astrocytes are induced by activated microglia.
Shane A Liddelow, Kevin A Guttenplan, Laura E Clarke, Frederick C Bennett, Christopher J Bohlen, Lucas Schirmer, Mariko L Bennett, Alexandra E Münch, Won-Suk Chung, Todd C Peterson,[...]. Nature 2017
Shane A Liddelow, Kevin A Guttenplan, Laura E Clarke, Frederick C Bennett, Christopher J Bohlen, Lucas Schirmer, Mariko L Bennett, Alexandra E Münch, Won-Suk Chung, Todd C Peterson,[...]. Nature 2017
7
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
Anthony H V Schapira, C Warren Olanow, J Timothy Greenamyre, Erwan Bezard. Lancet 2014
Anthony H V Schapira, C Warren Olanow, J Timothy Greenamyre, Erwan Bezard. Lancet 2014
7
Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
7
Genetic and environmental factors in the cause of Parkinson's disease.
Thomas T Warner, Anthony H V Schapira. Ann Neurol 2003
Thomas T Warner, Anthony H V Schapira. Ann Neurol 2003
7
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.
E R Dorsey, R Constantinescu, J P Thompson, K M Biglan, R G Holloway, K Kieburtz, F J Marshall, B M Ravina, G Schifitto, A Siderowf,[...]. Neurology 2007
E R Dorsey, R Constantinescu, J P Thompson, K M Biglan, R G Holloway, K Kieburtz, F J Marshall, B M Ravina, G Schifitto, A Siderowf,[...]. Neurology 2007
7
MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
6
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.
L F Lin, D H Doherty, J D Lile, S Bektesh, F Collins. Science 1993
L F Lin, D H Doherty, J D Lile, S Bektesh, F Collins. Science 1993
6
6
The importance of Wnt signalling for neurodegeneration in Parkinson's disease.
Daniel C Berwick, Kirsten Harvey. Biochem Soc Trans 2012
Daniel C Berwick, Kirsten Harvey. Biochem Soc Trans 2012
6
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
T Kitada, S Asakawa, N Hattori, H Matsumine, Y Yamamura, S Minoshima, M Yokochi, Y Mizuno, N Shimizu. Nature 1998
T Kitada, S Asakawa, N Hattori, H Matsumine, Y Yamamura, S Minoshima, M Yokochi, Y Mizuno, N Shimizu. Nature 1998
6
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.
Hui-Ming Gao, Jau-Shyong Hong. Trends Immunol 2008
Hui-Ming Gao, Jau-Shyong Hong. Trends Immunol 2008
6
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi,[...]. Ann Neurol 2011
Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi,[...]. Ann Neurol 2011
6
6
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
Hui-Ming Gao, Feng Zhang, Hui Zhou, Wayneho Kam, Belinda Wilson, Jau-Shyong Hong. Environ Health Perspect 2011
Hui-Ming Gao, Feng Zhang, Hui Zhou, Wayneho Kam, Belinda Wilson, Jau-Shyong Hong. Environ Health Perspect 2011
6
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.